High-grade urothelial carcinoma in a kidney transplant recipient with BK virus infection

NDT Plus

Volumn 2, Issue 3, 2009, Pages 242-245

  Hill, Prue ^a   Slavin, John ^a   Goodman, David ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

BK virus; Kidney transplant; PVN; Urothelial carcinoma

Indexed keywords

PROTEIN P53; VIRUS DNA; VIRUS T ANTIGEN;

ADULT; ARTICLE; BK VIRUS; BLADDER CARCINOMA; CANCER GRADING; CARCINOGENESIS; CASE REPORT; DISEASE COURSE; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; POLYOMAVIRUS NEPHROPATHY; PRIORITY JOURNAL; RECIPIENT; SIMIAN VIRUS 40; STAINING; VIRUS INFECTION;

EID: 77953954166     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfp013     Document Type: Article

References (14)

1. Kyle RA. Monoclonal proteins and renal disease. Annu Rev Med 1994; 45: 71-77
2. Lee CK, Zangari M, Barlogie B et al. Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant. Bone Marrow Transplant 2004; 33: 823-828
3. Alexanian R, Barlogie B, Dixon D. Renal failure in multiplemyeloma. Pathogenesis and prognostic implications. Arch Intern Med 1990; 150: 1693-1695
4. Ballester OF, Tummala R, Janssen WE et al. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency. Bone Marrow Transplant 1997; 20: 653-656
5. Badros A, Barlogie B, Siegel E et al. Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Br J Haematol 2001; 114: 822-829 (Pubitemid 32953738)
6. Bird JM, Fuge R, Sirohi B et al. British Society of Blood and Marrow Transplantation. The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study. Br J Haematol 2006; 134: 385-390
7. Knudsen LM, Hjorth M, Hippe E. Nordic Myeloma Study Group. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Eur J Haematol 2000; 65: 175-181
8. Dimopoulos MA, Kastritis E, Rosinol L et al. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia 2008; 22: 1485-1493
9. Bladé J, Fernández-Llama P, Bosch F et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 1998; 158: 1889-1893
10. Tauro S, Clark FJ, Duncan N et al. Recovery of renal function after autologous stem cell transplantation in myeloma patients with endstage renal failure. Bone Marrow Transplant 2002; 30: 471-473
11. Yokoo T, Kawamura T, Kobayashi E. Stem cells for kidney repair: useful tool for acute renal failure? Kidney Int 2008; 74: 847-849
12. Krause D, Cantley LG. Bone marrow plasticity revisited: protection or differentiation in the kidney tubule? J Clin Invest 2005; 115: 1705-1708
13. Duffield JS, Park KM, Hsiao LL et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005; 115: 1743-1755
14. Huls M, Russel FG, Masereeuw R. Insights into the role of bone marrow-derived stem cells in renal repair. Kidney Blood Press Res 2008; 31: 104-110